Monlunabant
Product Specifications
CAS Number
2712480-46-9
Synonyms
INV-202, (S) -MRI-1891
Target
Cannabinoid Receptor
Applications
Neuronal Signaling
Molecular Formula
C26H22ClF3N6O3S
Additionnal Information
Monlunabant (INV-202, (S) -MRI-1891) is a peripherally acting inverse agonist of the cannabinoid type-1 receptor (CB1R), with the potential to treat respiratory and renal complications associated with metabolic disorders. It improves lung compliance in a mouse model of asthma and reduces renal fibrosis in a streptozotocin-induced diabetic nephropathy mouse model.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1045968-01 0.02 mg (E-Coli)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details MBS1045968-02 0.02 mg (Yeast)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details MBS1045968-03 0.1 mg (E-Coli)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details MBS1045968-04 0.1 mg (Yeast)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details MBS1045968-05 0.02 mg (Baculovirus)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details MBS1045968-06 0.02 mg (Mammalian-Cell)
Recombinant Rhodobacter sphaeroides Ribulose bisphosphate carboxylase (cbbM)
Sign In for Pricing
View Details